PHENTERMINE RESIN 30 Drug Patent Profile
✉ Email this page to a colleague
When do Phentermine Resin 30 patents expire, and when can generic versions of Phentermine Resin 30 launch?
Phentermine Resin 30 is a drug marketed by Quantum Pharmics and is included in one NDA.
The generic ingredient in PHENTERMINE RESIN 30 is phentermine resin complex. There are seventeen drug master file entries for this compound. Additional details are available on the phentermine resin complex profile page.
Summary for PHENTERMINE RESIN 30
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 47 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PHENTERMINE RESIN 30 at DailyMed |
Recent Clinical Trials for PHENTERMINE RESIN 30
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) | Phase 4 |
Johns Hopkins University | Phase 4 |
WW International Inc. | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for PHENTERMINE RESIN 30
US Patents and Regulatory Information for PHENTERMINE RESIN 30
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quantum Pharmics | PHENTERMINE RESIN 30 | phentermine resin complex | CAPSULE, EXTENDED RELEASE;ORAL | 089120-001 | Feb 4, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |